Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SAB Biotherapeutics Inc.

    NASDAQ: SABS · Real-Time Price · USD
    2.00
    -0.18 (-8.26%)
    At close: Aug 19, 2025, 3:59 PM

    SAB Biotherapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -34.11M -42.19M -17.14M -17.14M
    Depreciation & Amortization
    		 4.79M 3.75M 3.29M 1.65M
    Stock-Based Compensation
    		 2.94M 2.42M 2.67M 2.31M
    Other Working Capital
    		 -3.17M -528.64K 3.83M 2.06M
    Other Non-Cash Items
    		 -5.62M 8.58M 1.48M 3.48M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -2.3M 2.33M 13.45M 13.45M
    Operating Cash Flow
    		 -34.29M -25.12M 3.76M 3.76M
    Capital Expenditures
    		 -337.26K -197.15K -10.94M -10.94M
    Cash Acquisitions
    		 n/a 44.45K 76.39K n/a
    Purchase of Investments
    		 -37.45M n/a n/a n/a
    Sales Maturities Of Investments
    		 25.82M n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a -76.39K n/a
    Investing Cash Flow
    		 -11.96M -152.7K -10.94M -10.94M
    Debt Repayment
    		 -907K -390.44K -1.19M 1.54M
    Common Stock Repurchased
    		 n/a n/a -5.52M n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -286.04K 59.66M 76.97K 32.57M
    Financial Cash Flow
    		 -1.17M 66.77M 1.05M 34.12M
    Net Cash Flow
    		 -47.67M 41.52M 26.93M 26.93M
    Free Cash Flow
    		 -34.63M -25.32M -7.19M -7.19M

    Add to Watchlist